Uzunalimoglu O - Search Results

1

Hepatitis B core antigen expression pattern reflects the response to anti-viral treatment.

Uzun Y, Bozkaya H, Erden E, Cinar K, Idilman R, Yurdaydin C, Uzunalimoglu O. Uzun Y, et al. Among authors: uzunalimoglu o. J Gastroenterol Hepatol. 2006 Jun;21(6):977-81. doi: 10.1111/j.1440-1746.2006.04263.x. J Gastroenterol Hepatol. 2006. PMID: 16724981

2

Famciclovir treatment of chronic delta hepatitis.

Yurdaydin C, Bozkaya H, Gürel S, Tillmann HL, Aslan N, Okçu-Heper A, Erden E, Yalçin K, Iliman N, Uzunalimoglu O, Manns MP, Bozdayi AM. Yurdaydin C, et al. Among authors: uzunalimoglu o. J Hepatol. 2002 Aug;37(2):266-71. doi: 10.1016/s0168-8278(02)00162-9. J Hepatol. 2002. PMID: 12127433 Clinical Trial.

3

Nuclear localization of hepatitis B core antigen and its relations to liver injury, hepatocyte proliferation, and viral load.

Serinoz E, Varli M, Erden E, Cinar K, Kansu A, Uzunalimoglu O, Yurdaydin C, Bozkaya H. Serinoz E, et al. Among authors: uzunalimoglu o. J Clin Gastroenterol. 2003 Mar;36(3):269-72. doi: 10.1097/00004836-200303000-00016. J Clin Gastroenterol. 2003. PMID: 12590241

4

P21 expression and its relation to disease activity and hepatocyte proliferation in chronic hepatitis B virus infection.

Varli M, Heper AO, Erden E, Uzunalimoğlu O, Yurdaydin C, Bozkaya H. Varli M, et al. Among authors: uzunalimoglu o. Turk J Gastroenterol. 2005 Mar;16(1):12-6. Turk J Gastroenterol. 2005. PMID: 16252182 Free article.

5

Remission of severe aplastic anemia associated with hepatitis B virus infection after viral clearance: potential role of lamivudine.

Bozkaya H, Yurdaydin C, Törüner M, Arat M, Bozdayi AM, Erekul S, Cinar K, Koç H, Uzunalimoğlu O. Bozkaya H, et al. Among authors: uzunalimoglu o. Dig Dis Sci. 2002 Aug;47(8):1782-5. doi: 10.1023/a:1016444611997. Dig Dis Sci. 2002. PMID: 12184530

6

Oral ganciclovir for treatment of lamivudine-resistant hepatitis B virus infection: a pilot study.

Bozkaya H, Yurdaydin C, Bozdayi AM, Erkan O, Karayalcin S, Uzunalimoglu O. Bozkaya H, et al. Among authors: uzunalimoglu o. Clin Infect Dis. 2002 Oct 15;35(8):960-5. doi: 10.1086/342907. Epub 2002 Sep 25. Clin Infect Dis. 2002. PMID: 12355383 Clinical Trial.

7

The mutations in ISDR of NS5A gene are not associated with response to interferon treatment in Turkish patients with chronic hepatitis C virus genotype 1b infection.

Aslan N, Bozdayi AM, Cetinkaya H, Sarioğlu M, Türkay C, Bozkaya H, Karayalçin S, Yurtaydin C, Uzunalimoğlu O. Aslan N, et al. Among authors: uzunalimoglu o. Turk J Gastroenterol. 2004 Mar;15(1):21-6. Turk J Gastroenterol. 2004. PMID: 15264117 Free article.

8

Lichen planus and HCV infection in Turkish patients.

Karavelioğlu D, Koytak ES, Bozkaya H, Uzunalimoğlu O, Bozdayi AM, Yurdaydin C. Karavelioğlu D, et al. Among authors: uzunalimoglu o. Turk J Gastroenterol. 2004 Sep;15(3):133-6. Turk J Gastroenterol. 2004. PMID: 15492909 Free article.

9

Thrombophilic gene mutations in cirrhotic patients with portal vein thrombosis.

Erkan O, Bozdayi AM, Disibeyaz S, Oguz D, Ozcan M, Bahar K, Karayalcin S, Ozden A, Bozkaya H, Yurdaydin C, Uzunalimoglu O. Erkan O, et al. Among authors: uzunalimoglu o. Eur J Gastroenterol Hepatol. 2005 Mar;17(3):339-43. doi: 10.1097/00042737-200503000-00013. Eur J Gastroenterol Hepatol. 2005. PMID: 15716659

10

Lamivudine treatment in HBeAg-negative chronic hepatitis B patients with low level viraemia.

Bozkaya H, Yurdaydin C, Idilman R, Tüzün A, Cinar K, Erkan O, Bozdayi AM, Erden E, Uzun Y, Cetinkaya H, Uzunalimoglu O. Bozkaya H, et al. Among authors: uzunalimoglu o. Antivir Ther. 2005;10(2):319-25. Antivir Ther. 2005. PMID: 15865226 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53 results

Search Page

Filters